|
FAM13A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.14840042925368E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15980003378979E-10 |
| Normal-vs-Stage2 |
2.300300E-03 |
| Normal-vs-Stage3 |
2.603600E-04 |
| Normal-vs-Stage4 |
4.419200E-03 |
| Stage1-vs-Stage2 |
7.755400E-01 |
| Stage1-vs-Stage3 |
9.265700E-02 |
| Stage1-vs-Stage4 |
1.198370E-01 |
| Stage2-vs-Stage3 |
2.629600E-01 |
| Stage2-vs-Stage4 |
2.613400E-01 |
| Stage3-vs-Stage4 |
9.103200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.20389953351241E-10 |
| Normal-vs-AfricanAmerican |
9.317600E-03 |
| Normal-vs-Asian |
3.299800E-02 |
| Caucasian-vs-AfricanAmerican |
5.824000E-01 |
| Caucasian-vs-Asian |
3.826600E-01 |
| AfricanAmerican-vs-Asian |
3.260600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.39220018530773E-10 |
| Normal-vs-Female |
1.61570000001277E-06 |
| Male-vs-Female |
3.288200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.189600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.30739999516206E-08 |
| Normal-vs-Age(61-80Yrs) |
1.52040002809883E-09 |
| Normal-vs-Age(81-100Yrs) |
5.677900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.597400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.945640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.210600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.260420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.965800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.613800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.656100E-03 |
| Normal-vs-Grade 2 |
1.87160287268284E-11 |
| Normal-vs-Grade 3 |
5.30070000004379E-07 |
| Normal-vs-Grade 4 |
4.191600E-01 |
| Grade 1-vs-Grade 2 |
4.572200E-01 |
| Grade 1-vs-Grade 3 |
2.648000E-01 |
| Grade 1-vs-Grade 4 |
4.223000E-03 |
| Grade 2-vs-Grade 3 |
1.786820E-01 |
| Grade 2-vs-Grade 4 |
3.51339999999922E-05 |
| Grade 3-vs-Grade 4 |
1.415820E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.17443857259059E-14 |
| Normal-vs-ccB subtype |
3.794500E-04 |
| ccA subtype-vs-ccB subtype |
7.042800E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.3019000002581E-07 |
| Normal-vs-N1 |
6.552400E-01 |
| N0-vs-N1 |
2.555400E-01 |
|
|
